Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Perjeta
Perjeta
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Street Insider
Tue, 07/2/13 - 09:38 am
Roche
Genentech
FDA
Perjeta
breast cancer
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
Roche looks to earn even more from Perjeta with EU nod
Fierce Pharma
Fri, 12/14/12 - 12:32 pm
Roche
Perjeta
Europe
breast cancer
Roche winning on Perjeta supply, but running short of Boniva
InPharm
Wed, 08/22/12 - 11:37 am
Perjeta
Boniva
Roche
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Xconomy
Fri, 06/8/12 - 11:51 am
FDA
breast cancer
Roche
Perjeta
Pertuzumab
Pages
« first
‹ previous
1
2